English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Background:  Subcutaneous recombinant human parathormone [rhPTH (1–34)] has been introduced for hypoparathyroidism treatment, allowing avoidance of vitamin D and calcium side effects.

Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism